Loss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells ...

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a ...

Neurofibromatosis type 1 (NF1) is a genetic disorder in which tumors grow on the peripheral nervous system. Most of these ...

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells ...

Systemic anti-cancer therapies, including chemotherapy, targeted therapies, immunotherapies, and hormone treatments, are essential components of modern oncology. In patients with metastatic disease, ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Researchers found that loss of GATA6 reprograms colorectal cancer cells into flexible, fetal-like states that can spread to ...

Glioblastoma (GBM) is the most common primary brain cancer with over 12,000 new cases per year in the US 1. Patients with GBM usually decline rapidly, with a 5-year survival rate of just 5% and a ...

UCT-led researchers decoded how cancer rewires the MUC1 protein’s sugar coating to evade immune detection, paving the way for ...

Cancer cells that disseminate from a tumor can enter a period of dormancy that may persist from months to decades before metastasis. Efforts to improve adjuvant therapy to remove residual cancer cells ...

In the intricate biology of the human body, organs such as the breast, the colon and the lungs are lined with a defensive barrier known as the epithelium. At the heart of this barrier sits a ...